Joost Breeksema

Postdoctoral researcher and Executive Director of the OPEN Foundation

Data updated

Papers

10 publications

Trials

0 clinical trials

Links

Research Footprint

Joost Breeksema appears in 10 tracked papers (2020–2025), most studied alongside MDMA, Psilocybin and Ketamine, across Anxiety Disorders, Depressive Disorders and PTSD.

Most-cited paper: Reviewing the potential of psychedelics for the treatment of PTSD (257 citations).

Frequent co-authors: Robert Schoevers, Eric Vermetten and Wim Van Den Brink.

Background & Research

Joost J. Breeksema is a Dutch philosopher and qualitative researcher focused on psychedelic-assisted and ketamine/esketamine treatments, with particular attention to patient experiences, safety, ethics, and policy. He has published on psilocybin, MDMA, adverse events in psychedelic treatments, and decision-making around MDMA policy. He has also served as Executive Director of the OPEN Foundation, which supports psychedelic research and the Interdisciplinary Conference on Psychedelic Research.

Affiliations

Institutions, companies, and organisations Joost Breeksema is associated with.